
Bibliography
Research using CPRD data has informed drug safety guidance and clinical practice and resulted in over 2,300 peer-reviewed publications.
The CPRD bibliography is updated on a monthly basis (last updated 4 December 2019) and papers are listed below and in the PDF below.
If you have published papers using CPRD data which are not included in this list, please contact us at enquiries@cprd.com so that we can update the bibliography.
Download:
(PDF, 3MB, 193 pages)
“Acetaminophen and the risk of renal and bladder cancer in the general practice research database”, Epidemiology, vol. 12, pp. 690-4, 2001.
, “Antihypertensive drugs and the risk of idiopathic aplastic anaemia”, Br J Clin Pharmacol, vol. 49, pp. 604-8, 2000.
, “Frequency of liver disease in type 2 diabetic patients treated with oral antidiabetic agents”, Diabetes Care, vol. 22, pp. 2067-71, 1999.
, “Postmenopausal estrogen replacement therapy and the risk of Alzheimer disease”, Arch Neurol, vol. 58, pp. 435-40, 2001.
, “Risk of idiopathic cardiovascular death and nonfatal venous thromboembolism in women using oral contraceptives with differing progestagen components”, Lancet, vol. 346, pp. 1589-93, 1995.
, “Risk of idiopathic cerebral haemorrhage in women on oral contraceptives with differing progestagen components”, Lancet, vol. 354, pp. 302-3, 1999.
, “The risk of sulfasalazine- and mesalazine-associated blood disorders”, Pharmacotherapy, vol. 15, pp. 176-81, 1995.
, “Terfenadine and risk of acute liver disease”, Br J Clin Pharmacol, vol. 46, pp. 251-3, 1998.
, “Use of dexfenfluramine, fenfluramine and phentermine and the risk of stroke”, Br J Clin Pharmacol, vol. 47, pp. 565-9, 1999.
,